FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321316620> ?p ?o ?g. }

• W2321316620 endingPage "306" @default.
• W2321316620 startingPage "297" @default.
• W2321316620 abstract "Traumatic brain injury (TBI) is an increasingly frequent and poorly understood condition lacking effective therapeutic strategies. Inflammation and oxidative stress (OS) are critical components of injury, and targeted interventions to reduce their contribution to injury should improve neurobehavioral recovery and outcomes. Recent evidence reveals potential protective, yet short-lived, effects of the endocannabinoids (ECs), 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl-ethanolamine (AEA), on neuroinflammatory and OS processes after TBI. The aim of this study was to determine whether EC degradation inhibition after TBI would improve neurobehavioral recovery by reducing inflammatory and oxidative damage. Adult male Sprague-Dawley rats underwent a 5-mm left lateral craniotomy, and TBI was induced by lateral fluid percussion. TBI produced apnea (17±5 sec) and a delayed righting reflex (479±21 sec). Thirty minutes post-TBI, rats were randomized to receive intraperitoneal injections of vehicle (alcohol, emulphor, and saline; 1:1:18) or a selective inhibitor of 2-AG (JZL184, 16 mg/kg) or AEA (URB597, 0.3 mg/kg) degradation. At 24 h post-TBI, animals showed significant neurological and -behavioral impairment as well as disruption of blood–brain barrier (BBB) integrity. Improved neurological and -behavioral function was observed in JZL184-treated animals. BBB integrity was protected in both JZL184- and URB597-treated animals. No significant differences in ipsilateral cortex messenger RNA expression of interleukin (IL)-1β, IL-6, chemokine (C-C motif) ligand 2, tumor necrosis factor alpha, cyclooxygenase 2 (COX2), or nicotinamide adenine dinucleotide phosphate oxidase (NOX2) and protein expression of COX2 or NOX2 were observed across experimental groups. Astrocyte and microglia activation was significantly increased post-TBI, and treatment with JZL184 or URB597 blocked activation of both cell types. These findings suggest that EC degradation inhibition post-TBI exerts neuroprotective effects. Whether repeated dosing would achieve greater protection remains to be examined." @default.
• W2321316620 created "2016-06-24" @default.
• W2321316620 creator A5007180025 @default.
• W2321316620 creator A5007494067 @default.
• W2321316620 creator A5018145014 @default.
• W2321316620 creator A5039998817 @default.
• W2321316620 creator A5055456818 @default.
• W2321316620 creator A5068516229 @default.
• W2321316620 date "2015-03-01" @default.
• W2321316620 modified "2023-09-23" @default.
• W2321316620 title "Endocannabinoid Degradation Inhibition Improves Neurobehavioral Function, Blood–Brain Barrier Integrity, and Neuroinflammation following Mild Traumatic Brain Injury" @default.
• W2321316620 cites W1517525911 @default.
• W2321316620 cites W1530968931 @default.
• W2321316620 cites W1550447348 @default.
• W2321316620 cites W1579085145 @default.
• W2321316620 cites W1965074869 @default.
• W2321316620 cites W1969278900 @default.
• W2321316620 cites W1971026392 @default.
• W2321316620 cites W1972820094 @default.
• W2321316620 cites W1983808643 @default.
• W2321316620 cites W1989058637 @default.
• W2321316620 cites W1990625273 @default.
• W2321316620 cites W1998106894 @default.
• W2321316620 cites W1999934730 @default.
• W2321316620 cites W2000489529 @default.
• W2321316620 cites W2003505305 @default.
• W2321316620 cites W2007081797 @default.
• W2321316620 cites W2008405891 @default.
• W2321316620 cites W2010527958 @default.
• W2321316620 cites W2026624933 @default.
• W2321316620 cites W2032715817 @default.
• W2321316620 cites W2034673751 @default.
• W2321316620 cites W2035040528 @default.
• W2321316620 cites W2039716354 @default.
• W2321316620 cites W2043013675 @default.
• W2321316620 cites W2043033522 @default.
• W2321316620 cites W204348490 @default.
• W2321316620 cites W2047408156 @default.
• W2321316620 cites W2051600991 @default.
• W2321316620 cites W2054467284 @default.
• W2321316620 cites W2062754118 @default.
• W2321316620 cites W2063536480 @default.
• W2321316620 cites W2063837435 @default.
• W2321316620 cites W2067487401 @default.
• W2321316620 cites W2068710494 @default.
• W2321316620 cites W2073814752 @default.
• W2321316620 cites W2078347439 @default.
• W2321316620 cites W2079168581 @default.
• W2321316620 cites W2081325915 @default.
• W2321316620 cites W2086458197 @default.
• W2321316620 cites W2087674201 @default.
• W2321316620 cites W2088917874 @default.
• W2321316620 cites W2092535327 @default.
• W2321316620 cites W2094720192 @default.
• W2321316620 cites W2096869950 @default.
• W2321316620 cites W2098025305 @default.
• W2321316620 cites W2104586148 @default.
• W2321316620 cites W2106136779 @default.
• W2321316620 cites W2116885817 @default.
• W2321316620 cites W2127338217 @default.
• W2321316620 cites W2130587723 @default.
• W2321316620 cites W2142460361 @default.
• W2321316620 cites W2146373526 @default.
• W2321316620 cites W2147783395 @default.
• W2321316620 cites W2148927308 @default.
• W2321316620 cites W2149233326 @default.
• W2321316620 cites W2149381430 @default.
• W2321316620 cites W2150675101 @default.
• W2321316620 cites W2160935383 @default.
• W2321316620 cites W2611319797 @default.
• W2321316620 cites W2736091234 @default.
• W2321316620 doi "https://doi.org/10.1089/neu.2014.3508" @default.
• W2321316620 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4348366" @default.
• W2321316620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25166905" @default.
• W2321316620 hasPublicationYear "2015" @default.
• W2321316620 type Work @default.
• W2321316620 sameAs 2321316620 @default.
• W2321316620 citedByCount "70" @default.
• W2321316620 countsByYear W23213166202015 @default.
• W2321316620 countsByYear W23213166202016 @default.
• W2321316620 countsByYear W23213166202017 @default.
• W2321316620 countsByYear W23213166202018 @default.
• W2321316620 countsByYear W23213166202019 @default.
• W2321316620 countsByYear W23213166202020 @default.
• W2321316620 countsByYear W23213166202021 @default.
• W2321316620 countsByYear W23213166202022 @default.
• W2321316620 countsByYear W23213166202023 @default.
• W2321316620 crossrefType "journal-article" @default.
• W2321316620 hasAuthorship W2321316620A5007180025 @default.
• W2321316620 hasAuthorship W2321316620A5007494067 @default.
• W2321316620 hasAuthorship W2321316620A5018145014 @default.
• W2321316620 hasAuthorship W2321316620A5039998817 @default.
• W2321316620 hasAuthorship W2321316620A5055456818 @default.
• W2321316620 hasAuthorship W2321316620A5068516229 @default.
• W2321316620 hasBestOaLocation W23213166202 @default.
• W2321316620 hasConcept C118552586 @default.
• W2321316620 hasConcept C126322002 @default.
• W2321316620 hasConcept C170493617 @default.

• next